(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Countdown: Apple, Ferrari, and Novo Nordisk Take the Stage

  • October 29th, 2023
  • 428 views

On Thursday, November 2, a range of significant companies are anticipated to unveil their financial performance, including:

Apple Inc. (Nasdaq: AAPL), a renowned tech giant, is set to disclose its fourth-quarter fiscal 2023 financial results after the market's closure. 

Analysts are forecasting earnings per share (EPS) of $1.31 on revenue totaling $84.18 billion.

$AAPL closed at $168.22 on Friday, up $1.33 (+0.80%).

Ferrari N.V. (NYSE: RACE), an Italian luxury sports car manufacturer, will release its financial results for the third quarter of 2023 before the market opens.

The consensus EPS estimate is $1.68, complemented by revenue totaling $1.57 billion.

On Friday, $RACE closed at $298.24, reflecting an increase of $1.13 (+0.38%).

Novo Nordisk A/S (NYSE: NVO), a leading pharmaceutical company, is expected to report its financial results for the third quarter and the first nine months of 2023 prior to the market opening. 

Analysts are expecting an EPS of $0.71 on revenue amounting to $7.91 billion.

$NVO closed at $93.50 on Friday, reflecting a decrease of $1.70 (-1.79%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13